• 1. CCLVI.—A preparation of sarcosine
  Wesley Cocker,Arthur Lapworth J. Chem. Soc. 1931 1894

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzamides

Introduction to 2-(N-methyl-1-phenylformamido)acetic acid (CAS No. 2568-34-5)

2-(N-methyl-1-phenylformamido)acetic acid, identified by the Chemical Abstracts Service Number (CAS No.) 2568-34-5, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This molecule, featuring a unique structural motif combining an amide and an acetic acid moiety, has garnered attention due to its versatile applications in medicinal chemistry and drug development. The presence of a N-methyl-1-phenylformamido group suggests potential interactions with biological targets, making it a valuable scaffold for designing novel therapeutic agents.

The compound’s structure consists of a phenyl ring linked to an amide group, which is further connected to an acetic acid derivative. This configuration allows for multiple points of chemical modification, enabling chemists to tailor its properties for specific biological activities. In recent years, the exploration of such heterocyclic amides has been a focal point in the development of small-molecule drugs, particularly in the treatment of neurological disorders and inflammatory conditions.

Recent advancements in computational chemistry have enhanced our understanding of how 2-(N-methyl-1-phenylformamido)acetic acid interacts with biological systems. Molecular docking studies have revealed that this compound can bind to various protein targets, including enzymes and receptors involved in metabolic pathways. Such findings have spurred interest in its potential as a lead compound for drug discovery programs targeting diseases like diabetes and cancer.

In the context of drug design, the N-methyl-1-phenylformamido moiety serves as a critical pharmacophore, influencing both the solubility and binding affinity of the molecule. Modifications to this group can significantly alter its pharmacokinetic properties, making it essential to optimize its structure for therapeutic efficacy. Researchers have employed techniques such as structure-activity relationship (SAR) studies to systematically modify key functional groups and assess their impact on biological activity.

One notable application of 2-(N-methyl-1-phenylformamido)acetic acid is in the synthesis of protease inhibitors, which are crucial for treating viral infections and cancer. The amide bond in this compound can be strategically positioned to mimic natural substrates or transition states of target enzymes, thereby inhibiting their activity. Preliminary studies have shown promising results when this molecule is incorporated into peptidomimetics designed to disrupt viral replication cycles.

The acetic acid moiety in 2-(N-methyl-1-phenylformamido)acetic acid also contributes to its versatility, as it can participate in hydrogen bonding interactions within biological targets. This feature has been exploited in the design of kinase inhibitors, where precise positioning of acidic groups is essential for optimal binding affinity. Furthermore, the phenyl ring provides a hydrophobic surface that can enhance membrane permeability, improving oral bioavailability—a critical factor in drug development.

Emerging research has also explored the use of 2-(N-methyl-1-phenylformamido)acetic acid as a building block for more complex derivatives via cross-coupling reactions such as Suzuki-Miyaura coupling or Buchwald-Hartwig amination. These transformations allow for the introduction of diverse functional groups while maintaining the core pharmacophoric features necessary for biological activity. Such synthetic strategies have opened new avenues for creating novel therapeutics with tailored properties.

The compound’s stability under various conditions has been another area of interest. Studies have demonstrated that 2-(N-methyl-1-phenylformamido)acetic acid remains stable under moderate temperatures and acidic environments, suggesting its suitability for formulation into solid dosage forms like tablets or capsules. However, further investigations are needed to assess its long-term stability under extreme pH conditions or when exposed to light-sensitive environments.

From a regulatory perspective, ensuring compliance with Good Manufacturing Practices (GMP) is essential when producing 2-(N-methyl-1-phenylformamido)acetic acid on an industrial scale. Quality control measures must be implemented to monitor impurities and ensure batch-to-batch consistency. Analytical techniques such as high-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry (MS) are routinely employed to verify purity and structural integrity.

The future prospects of 2-(N-methyl-1-phenylformamido)acetic acid are promising, with ongoing research exploring its potential in areas beyond traditional pharmaceutical applications. For instance, its incorporation into materials science has shown promise for developing functional polymers with enhanced mechanical or electronic properties. Additionally, its role as an intermediate in organic synthesis may lead to novel methodologies for constructing complex molecules efficiently.

In conclusion,2-(N-methyl-1-phenylformamido)acetic acid (CAS No. 2568-34-5) represents a fascinating compound with broad utility across multiple scientific disciplines. Its unique structural features make it an attractive scaffold for drug discovery programs targeting various diseases, while its synthetic versatility allows for diverse modifications to optimize biological activity. As research continues to uncover new applications and refine synthetic methodologies,this compound is poised to remain at the forefront of innovation in chemical biology and medicinal chemistry.

• 495-69-2(2-(phenylformamido)acetic acid)
• 69826-63-7(2-(Naphthalen-2-ylformamido)acetic Acid)
• 27115-49-7(3-Methyl Hippuric Acid)
• 53518-98-2(Hippuric Acid-d5)
• 23082-14-6(2-(3,5-dimethylphenyl)formamidoacetic Acid)
• 23082-12-4(2-(3,4-Dimethylphenyl)formamidoacetic Acid)
• 27115-50-0(4-Methyl Hippuric Acid)
• 66407-11-2(2-Benzamidoacetic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)